LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF
LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF
Active, not recruiting · NCT05983250 · Registry updated 2026-07-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF | cardiovascular disorder, heart disorder, heart failure, hypertensive disorder, lung disorder, pulmonary hypertension, respiratory system disorder, vascular disorder | Active, not recruiting | Phase 3 | 2026-07-24 | NCT05983250 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Medpace, Inc. | 17 |
| Northwestern University | 381 |
| Tenax Therapeutics, Inc. | 3 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||